Outlook Therapeutics: Notable Insider Buys

 

• Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty.
• Some insiders have been taking advantage of secondary offerings recently.
• Others have been adding to their stakes in the wake of earnings reports.

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets. Note that with earnings reporting season in full swing, buy windows for many insiders are closed.

Here are some of the most noteworthy insider purchases that were reported in the past week.

Outlook Therapeutics Inc OTLK had a 10% owner and a director both increase their stakes last week. They acquired 11.36 million shares altogether, at a secondary offering price of $1 per share.

https://www.benzinga.com/news/21/02/19524828/notable-insider-buys-of-the-past-week-harley-davidson-texas-instruments-and-more